FindTrial
Sign In

HEPATITIS B SURFACE ANTIGEN

BIOLOGICAL2 trials

Sponsors

CHRU De Nancy, Central Hospital, Nancy, France

Conditions

Cirrhosis, LiverCirrhotic patients who have already received a HBV vaccination with a conventional regimen and who have not responded (characterized by a level of antibody Hbs < 10UI/ml at the end of the vaccine regimen)HBVVaccination FailureVaccine Reaction

Phase 2

Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
NCT05028322
Central Hospital, Nancy, FranceCirrhosis, Liver, HBV, Vaccination Failure +1
Start: 2021-11-01End: 2024-12-01Target: 60Updated: 2021-08-31
Effectiveness and Safety of Intra-Dermal Hepatitis B Vaccination after topical application of IMIQUIMOD, in cirrhotic patients, who did not respond to the conventional vaccine regimen: a pilot study
CompletedCTIS2024-514605-61-00
CHRU De NancyCirrhotic patients who have already received a HBV vaccination with a conventional regimen and who have not responded (characterized by a level of antibody Hbs < 10UI/ml at the end of the vaccine regimen)
Start: 2022-07-08End: 2025-01-22Target: 60Updated: 2024-06-26